Camp4 Therapeutics Investor Relations Material
Latest events
Q2 2025
13 Aug, 2025
Q1 2025
13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Camp4 Therapeutics Corp
Access all reports
Camp4 Therapeutics Corp is a biotechnology company focused on developing RNA-based therapeutics. The company leverages a proprietary platform to identify and regulate gene expression through RNA technologies, aiming to address a range of diseases driven by dysregulated gene activity. Camp4 Therapeutics' research and development activities span multiple therapeutic areas, applying its platform to discover potential treatments targeting specific genetic mechanisms. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Camp4 Therapeutics Corp
43rd Annual J.P. Morgan Healthcare Conference
Camp4 Therapeutics Corp
43rd Annual J.P. Morgan Healthcare Conference
Camp4 Therapeutics Corp
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CAMP
Country
🇺🇸 United States